-
Friday, 07/12/2019
Prof. Antoni Torres considered Top Expertise in Respiratory Tract Infections Worldwide
Information available online and based on 98,806 articles published since 2008
Prof. Antoni Torres, the IAMR group leader, is very high ranked on the source:
http://www.expertscape.com/ex/respiratory+tract+infections in which a ranking for country, city or institution are also available based on 98,806 scientific and clinical articles published since 2008.
-
Monday, 06/17/2019
First scientific Workshop for patients with bronchiectasis
The workshop was sponsorized by SEPAR pacientes, GlaxoSmithKline (GSK), Mundipharma and Chiesi and it was organized by the Dr. Torres bronchiectasis group at Hospital Clínic
Ninety five patients attended the last 31st of May the first scientific Workshops addressed to patients who suffered from bronchiectasis. The Workshops program included the inaugural welcome message from Dr. Antoni Torres, the head of the respiratory ICU and bronchiectasis monographic consultation at the Hospital Clinic and Dr. Joan Albert Barberà, Head of Pneumology Service of the Hospital Clinic. Dr. Carmen Hernández, as responsible for “dispositivo transversal de hospitalización a domicilio” also participated during the opening. Then, the program included three scientific presentations by Dr. Rosanel Amaro, coordinator of the bronchiectasis monographic consultation at the Hospital Clinic, Victoria Alcaraz, specialist in respiratory physiotherapy focused in bronchiectasis, Dr. Laia Fernández-Barat, coordinator of the research microbiology laboratory, Marta Almagro, a very involved patient diagnosed from bronchiectasis when she was a child and María Rodríguez, representative of the association of patients with hypertension.
-
Monday, 06/17/2019
The IAMR research team has been successful in the 2018 call for the Spanish Society of Pneumology and Thoracic Surgery (SEPAR)
The SEPAR 2018 Grants of Fundació Respira (Spanish Lung Foundation) will invest around 600.000 euros in research
Antoni Torres, Miquel Ferrer, Enric Barbeta, Laia Fernández and Catia Cilloniz and obtained funding from the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) - Fundació Respira grants (http://www.separ.es) to carry out their research projects in the field of respiratory diseases.
Prof. Dr. Antoni Torres obtained a SEPAR 2018 grant for his project: Cardiac injury due to severe pneumococcal pneumonia: an evaluation of the effects of corticosteroids and macrolides.
Dr. Miquel Ferrer and Enric Barbeta obtained a SEPAR 2018 grant for his project: Mechanical Power, Driving Pressure and Biotrauma in the acute respiratory distress syndrome.
Dr. Laia Fernández-Barat obtained a SEPAR 2018 grant for his project: The importance of Pseudomonas aeruginosa biofilms in the exacerbations of patients with bronchiectasis with or without chronic obstructive pulmonary diseases.
Dr. Catia Cilloniz obtained a SEPAR 2018 grant for his project: Characterization of the acquired immune response in patients with community acquired pneumonia.
SEPAR-Fundació Respira awards a number of grants each year with the aim of encouraging research in the field of respiratory disease.
-
Tuesday, 05/14/2019
Dr. Catia Cillóniz receives the distinction of "Fellow of ERS (FERS) 2019" from the European Respiratory Society
This distinction recognizes excellence in research, education and clinical leadership in the area of respiratory medicine
Dr. Cilloniz is a researcher at the Pneumology Service of Hospital Clinic de Barcelona, researcher CIBERES, member of the SEPAR, associate professor at the University of Barcelona and coordinator of the research line on Community- Acquired Pneumonia.
The new "Fellows of ERS (FERS)" are selected each year based on their publication history and their outstanding contributions to the field of respiratory medicine. In addition to the prestige that the title confers, the FERS form an advisory board of the Society to intervene on relevant issues of respiratory medicine.
-
Thursday, 04/04/2019
The bronchiectasis research line awarded by the Catalan Society of Pneumology
The award was for the oral comunication on Pseudomonas aeruginosa and viscoelastic proprierties of mucus
Victoria Alcaraz, member of our research team, received the first price to the best oral communication on the area of fisiotherapy and respiratory nursing in the XXXVII pneumological day of Catalan Society of Pneumology (SOCAP) for her investigations in the alterations of the viscoelasticity properties of the mucus by the presence of mucoid Pseudomonas aeruginosa in bronchiectasis patients.
-
Monday, 03/25/2019
Gianluigi Li Bassi selected by the BITRECS program in Prof. Antoni Torres research group
This competitive program selects excellent clinicians-scientist for translational research environment of IDIBAPS
The second call for the program 'Biomedicine international training research program for excellent clinician-scientists' (BITRECS) has been resolved.
Dr. Gianluigi Li Bassi: From Italy, he lives in Australia. He joins the research group Applied Research in Respiratory Diseases, directed by Prof. Antoni Torres, in the outgoing format: part of the project will be carried out at IDIBAPS and part in Australia, with a brief stay in Brazil. -
Monday, 03/25/2019
Prof. Antoni Torres Martí group leader of IAMR research group among the first 20 Spanish scientist according to their Google Scholar Citations public profiles
He achieved the position 18 of the first 5000 highly cited scientist in the twelfth edition of the Ranking of Spanish researchers and researchers working in Spanish Institutions (Spain)
After a whole career dedicated to clinical and translational research Prof. Antoni Torres is arguably one of the most important and most prolific investigators in the field of adult respiratory infections and critically ill patients. He has contributed seminal publications of high impact in the fields of community acquired and nosocomial pneumonia, producing both clinical and basic research.
-
Monday, 03/11/2019
Cristina Dominedò is successfully concluding her research stay in the IAMR group
During her fellowship she focused on studies concerning nosocomial pneumonia and community-acquired pneumonia
Cristina Dominedò joined the IAMR group guided by Prof. Antoni Torres in April 2018. She investigated the risk factors for multi drug resistant pathogens identified in the 2017 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. The results of her fellowship project will be presented at the 39th International Symposium on Intensive Care and Emergency Medicine in Bruxelles. During her one year fellowship she also assessed the role of surveillance cultures and follow up microbiology in the management of nosocomial pneumonia.
Her activity in the line of community-acquired pneumonia was focused on very old patients with sepsis and CAP, viral sepsis in adults with CAP, CAP caused by PES pathogens and the role of new antibiotics in the treatment of CAP.
-
Sunday, 11/18/2018
Roberto Cabrera and Anna Motos presented the results of two studies at the latest Jornadas de formación Ciberes
The meeting was hold last 15-16 of november 2018 in Madrid and involved more than 100 national researchers, 20 oral presentations and 40 posters on respiratory diseases and lung cancer
Roberto Cabrera, postodoctoral Ciberes researcher presented an oral presentation entitled: “Molecular characterization of antibiotic resistance mechanisms in methicilin- resistant Staphylococcus aureus from ICU endotracheal tubes”.
Anna Motos, Ciberes researcher and coordinator of animal Studies, presented a poste ron the study entitled “Is One Sample Enough? β-lactam Target Attainment and Penetration into Epithelial Lining Fluid based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia Model”.
-
Friday, 11/09/2018
IAMR achieved funding for two projects at the health national call 2018 (FIS)
The success warrants funding for the next three years in the laboratory and in the ventilador associated research lines
Dr. Antoni Torres and Dr. Laia Fernández Barat co-leaded the project entitled “Importance of Pseudomonas aeruginosa biofilms in exacerbations in patients with bronchiectasis with and without Chronic Obstructive pulmonary disease ”. This project achieved 196.000 euros.
Dr. Miquel Ferrer leaded the project entitled “Driving Pressure and Inflammation in Acute Respiratory Distress Syndrome”. This Project achieved 147.000 euros and will be the end of residency project of Enric Barbeta.
